AXSM
Price
$177.01
Change
+$2.68 (+1.54%)
Updated
Jan 14 closing price
Capitalization
8.92B
46 days until earnings call
Intraday BUY SELL Signals
PLRX
Price
$1.31
Change
+$0.02 (+1.55%)
Updated
Jan 14 closing price
Capitalization
80.5M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AXSM vs PLRX

Header iconAXSM vs PLRX Comparison
Open Charts AXSM vs PLRXBanner chart's image
Axsome Therapeutics
Price$177.01
Change+$2.68 (+1.54%)
Volume$457.43K
Capitalization8.92B
Pliant Therapeutics
Price$1.31
Change+$0.02 (+1.55%)
Volume$826.19K
Capitalization80.5M
AXSM vs PLRX Comparison Chart in %
View a ticker or compare two or three
VS
AXSM vs. PLRX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Hold and PLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AXSM: $177.01 vs. PLRX: $1.31)
Brand notoriety: AXSM and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXSM: 71% vs. PLRX: 62%
Market capitalization -- AXSM: $8.92B vs. PLRX: $80.5M
AXSM [@Biotechnology] is valued at $8.92B. PLRX’s [@Biotechnology] market capitalization is $80.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXSM’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • AXSM’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, AXSM is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXSM’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • AXSM’s TA Score: 4 bullish, 4 bearish.
  • PLRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AXSM is a better buy in the short-term than PLRX.

Price Growth

AXSM (@Biotechnology) experienced а +3.70% price change this week, while PLRX (@Biotechnology) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

AXSM is expected to report earnings on Mar 02, 2026.

PLRX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($8.92B) has a higher market cap than PLRX($80.5M). PLRX YTD gains are higher at: 7.377 vs. AXSM (-3.083). PLRX has higher annual earnings (EBITDA): -170.45M vs. AXSM (-213.94M). AXSM has more cash in the bank: 325M vs. PLRX (242M). PLRX has less debt than AXSM: PLRX (59.9M) vs AXSM (219M). AXSM has higher revenues than PLRX: AXSM (561M) vs PLRX (0).
AXSMPLRXAXSM / PLRX
Capitalization8.92B80.5M11,086%
EBITDA-213.94M-170.45M126%
Gain YTD-3.0837.377-42%
P/E RatioN/AN/A-
Revenue561M0-
Total Cash325M242M134%
Total Debt219M59.9M366%
FUNDAMENTALS RATINGS
AXSM: Fundamental Ratings
AXSM
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
34
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXSMPLRX
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 7 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
AXSM
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNDFX9.000.08
+0.90%
Manning & Napier Disciplined Value I
VSOIX47.860.30
+0.63%
Victory Sycamore Small Company Opp I
NTKLX77.050.26
+0.34%
Voya Multi-Manager International Sm Cp A
BINCX25.470.05
+0.20%
Brandes International Small Cap Equity C
VITSX165.98-0.73
-0.44%
Vanguard Total Stock Market Idx I

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
+1.54%
XENE - AXSM
37%
Loosely correlated
+3.02%
VANI - AXSM
36%
Loosely correlated
-0.78%
PLRX - AXSM
35%
Loosely correlated
+1.55%
SYRE - AXSM
35%
Loosely correlated
+5.17%
VNDA - AXSM
33%
Loosely correlated
+3.49%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+1.55%
LXRX - PLRX
42%
Loosely correlated
+3.33%
FHTX - PLRX
40%
Loosely correlated
-5.54%
OCUL - PLRX
37%
Loosely correlated
+6.14%
SLDB - PLRX
37%
Loosely correlated
+12.60%
ACHV - PLRX
36%
Loosely correlated
+1.63%
More